This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.

Dev

Joined: October 9, 2025
Articles: 6278

JPND Publications

Does participation in the Meeting Centre Support Programme change the stigma experienced by people with dementia?

“Does participation in the Meeting Centre Support Programme change the stigma experienced by people with dementia?” has been published in the journal European Psychiatry. This work was supported by JPND through the MEETINGDEM project, selected in the 2012 Healthcare Evaluation…

Dev
July 10, 2017

Research News (General)

Protein that regulates brain cell connections could be new target for treating Alzheimer’s

In experiments with a protein called Ephexin5 that appears to be elevated in the brain cells of Alzheimer’s disease patients and mouse models of the disease, researchers show that removing it prevents animals from developing Alzheimer’s characteristic memory losses. In…

Dev
July 10, 2017

JPND Publications

Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease

“Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease” has been published in the journal Neurology. This work was supported in part by JPND through the STRENGTH and RiMod-FTD projects, selected in the 2012 Risk…

Dev
July 7, 2017

Research News (General)

New Gene Identified in ALS

For the first time, a variant in UBQLN4 gene has been associated with amyotrophic lateral sclerosis (ALS; also known as Lou Gehrig’s disease) – a progressive disease resulting in the loss of nerve cells that control muscle movement, which eventually…

Dev
July 7, 2017

Research News (General)

Scientists identify the structure of tau filaments from Alzheimer’s disease

Researchers have, for the first time, revealed the atomic structures of one of the two types of the abnormal filaments which lead to Alzheimer’s disease. Understanding the structures of these filaments will be key in developing drugs to prevent their…

Dev
July 6, 2017

JPND Publications

Decreased plasma β-amyloid in Alzheimer’s disease APP A673T variant carriers

“Decreased plasma β-amyloid in the Alzheimer’s disease APP A673T variant carriers” has been published in the journal Annals of Neurology. This work was supported in part by JPND through the EADB project, selected in the 2015 JPco-fuND call.

Dev
July 6, 2017

Research News (General)

In Huntington’s disease, traffic jams in the cell’s control center kill brain cells

Working with mouse, fly and human cells and tissue, researchers report new evidence that disruptions in the movement of cellular materials in and out of a cell’s control center — the nucleus — appear to be a direct cause of…

Dev
July 6, 2017

Research News (General)

Antibody helps detect protein implicated in Alzheimer’s, other diseases

A team of researchers has found a way to measure tau levels in the blood. The method accurately reflects levels of tau in the brain that correlate with neurological damage. The study, in mice and a small group of people,…

Dev
July 5, 2017

JPND Publications

Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders

“Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders” has been published in the journal Clinical Epigenetics. This work was supported in part by JPND through the EPI-AD project, selected in the 2015 JPco-fuND call.

Dev
July 5, 2017

JPND Publications

Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome

“Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study“ has been published in the journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. This work was supported in part by JPND through the STRENGTH project,…

Dev
July 4, 2017

Post

Post